Algo version: 0.98b
Lotus Eye Hospital and is listed at the NSE Exchange
Lotus Eye Hospital and [LOTUSEYE.NS]
NSE Sector: Healthcare Industry:Medical Care Facilities

Is Lotus Eye Hospital and stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Lotus Eye Hospital and pays dividends. Last time was Wednesday 25th of October 2023 where the investors holding the stock on Monday 18th of September 2023 were paid INR0.5 per share. Over the last 5 times between 2017 and 2023, Lotus Eye Hospital and has paid INR2.5 with an average of INR0.5 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Lotus Eye Hospital and 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR19.70, you would have made a profit of INR57.81 per share or 293.45%

Yes, the average daily trading liquidity for Lotus Eye Hospital and is INR186 253 thousand. You should therefore be able to get in and out of your positions relatively fast.

Lotus Eye Hospital and has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 6.10, the company's ability to pay off the debt is good. Lotus Eye Hospital and has a good net profit margin of 6.05% and should have high tolerances against inflation.

We have calculated the inflation risk for Lotus Eye Hospital and to be low [0.1 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.